Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
得克萨斯州奥斯汀, Oct. 24, 2026 (GLOBE NEWSWIRE) -- 在得克萨斯州奥斯汀举行的 2026 年 FORMULA 1® MSC CRUISES UNITED STATES GRAND PRIX 期间，Del Valle ISD Education Foundation 荣获 F1® Allwyn 全球社......
Guangzhou, China, Oct. 24, 2026 (GLOBE NEWSWIRE) -- Tec-Do today hosted Technology Growth Conference 2026 (TGC 2026) in Guangzhou under the theme “AI is Profitable.” Featuring AI pioneer Dr. Kevin K......
